Related Experiment Video
Updated: Jan 27, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma
Chengyong Guo1, Chaohui Liang1, Jipeng Yang1
1Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.
Abstract:
As a core kinase in the Hippo pathway, large tumor suppressor kinase 2 (LATS2) regulates cell proliferation, migration and invasion through numerous signaling pathways. However, its functions on cell proliferation, migration and invasion in glioma have yet to be elucidated. The present study revealed that LATS2 was downregulated in glioma tissues and cells, as determined by reverse transcription‑quantitative polymerase chain reaction and immunohistochemistry. In addition, Cell Counting Kit‑8, scratch wound healing and Transwell assays revealed that overexpression of LATS2 in U‑372 MG cells inhibited cell proliferation, migration and invasion. Furthermore, western blot analysis indicated that the expression levels of phosphorylated (p)‑yes‑associated protein and p‑tafazzin were increased in cells with LATS2 overexpression. These results indicated that LATS2 is a potential tumor suppressor, and downregulation of LATS2 in glioma may contribute to cancer progression.
Insights
Large tumor suppressor kinase 2 (LATS2) acts as a tumor suppressor in glioma. Downregulation of LATS2 inhibits cell proliferation, migration, and invasion, suggesting its role in glioma progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The Hippo pathway is crucial for organ size control.
- Large tumor suppressor kinase 2 (LATS2) is a core kinase in the Hippo pathway.
- The role of LATS2 in glioma progression is not fully understood.
Purpose of the Study:
- To investigate the function of LATS2 in glioma.
- To determine the expression levels of LATS2 in glioma tissues and cells.
- To elucidate the underlying molecular mechanisms of LATS2 in regulating glioma cell behaviors.
Main Methods:
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and immunohistochemistry were used to assess LATS2 expression.
- Cell Counting Kit-8, scratch wound healing, and Transwell assays were performed to evaluate cell proliferation, migration, and invasion.
- Western blot analysis was employed to detect the expression of key signaling molecules.
Main Results:
- LATS2 expression was significantly downregulated in glioma tissues and cells compared to normal tissues.
- Overexpression of LATS2 in U-372 MG glioma cells suppressed cell proliferation, migration, and invasion.
- LATS2 overexpression led to increased levels of phosphorylated yes-associated protein (p-YAP) and phosphorylated tafazzin (p-TAZ).
Conclusions:
- LATS2 functions as a tumor suppressor in glioma.
- Downregulation of LATS2 contributes to glioma progression.
- Targeting LATS2 may represent a potential therapeutic strategy for glioma treatment.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Insulin: The Receptor and Signaling Pathways
IP3/DAG Signaling Pathway
Nitric Oxide Signaling Pathway

